w

S

3

(e.g. a drug or stimulation of a neuronal system), and it may commonly associated with dopamine signalling within the Ss

therefore be more difficult to interpret the basal neurochemical OFC, and more commonly associated with striatal and mPFC ~~
levels obtained in our study. Fourth, it is unclear if these neuro- dopamine signalling [86,89-92]. Our data may therefore
chemical abnormalities disrupt brain or behaviour function, point to a unique regional mechanism of monoaminergic dys-
and they could instead represent a compensatory process. function relevant to OCD. Of particular interest in this context
This could be consistent with the absence of correlations is the fact that dopaminergic innervation of OFC is relatively
between post-mortem monoamine content and the observed weak compared with striatum and mPFC [93]; thus, modest
grooming phenotype that survived multiple comparisons. abnormalities in OFC dopamine levels could represent a
Finally, because mice cannot model all aspects of a human psy- strong functional change in OFC. It will therefore be important
chiatric disorder, it is possible that the SAPAP3-KO model does to use in vivo approaches to precisely measure or control OFC
not accurately reflect serotonergic pathology in OCD patients. dopamine signalling and examine the impact on performance

In vivo studies in SAPAP3-KOs examining the relationship of tasks impaired in OCD.

between monoaminergic signalling and behaviour will yield
more insight into these possibilities.

(c) Emerging technologies to further understand